Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 1,051–1,100 of 1,201 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05668962	Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC	recruiting	Phase 2	30	Massachusetts General HospitalOTHER	1	Dec 12, 2024	clinicaltrials
NCT06725498	Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC	recruiting	Phase 2	50	Beijing Tongren HospitalOTHER	1	Dec 10, 2024	clinicaltrials
NCT02185443